Letter

Switching prescription drugs to over the counter: Consumers may benefit financially in examples from the US

BMJ 2005; 330 doi: 10.1136/bmj.330.7496.904-c (Published 14 April 2005)
Cite this as: BMJ 2005;330:904.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Patrick W Sullivan (Patrick.Sullivan@UCHSC.edu), assistant professor, school of pharmacy
  1. Pharmaceutical Outcomes Research Program, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Box C238, Denver, CO 80262, USA

    EDITOR—Cohen et al say that switching drugs to over the counter increases costs for most insured patients in the United States because of resultant changes in drug benefits.1 Most health plans restrict drug coverage and increase copayments when one member of the class is made available over the counter. However, evidence from recent switches from prescription to over the counter shows that …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular